Literature DB >> 21824805

Viruses exploiting peroxisomes.

Paul B Lazarow1.   

Abstract

Viruses that are of great importance for global public health, including HIV, influenza and rotavirus, appear to exploit a remarkable organelle, the peroxisome, during intracellular replication in human cells. Peroxisomes are sites of lipid biosynthesis and catabolism, reactive oxygen metabolism, and other metabolic pathways. Viral proteins are targeted to peroxisomes (the spike protein of rotavirus) or interact with peroxisomal proteins (HIV's Nef and influenza's NS1) or use the peroxisomal membrane for RNA replication. The Nef interaction correlates strongly with the crucial Nef function of CD4 downregulation. Viral exploitation of peroxisomal lipid metabolism appears likely. Mostly, functional significance and mechanisms remain to be elucidated. Recently, peroxisomes were discovered to play a crucial role in the innate immune response by signaling the presence of intracellular virus, leading to the first rapid antiviral response. This review unearths, interprets and connects old data, in the hopes of stimulating new and promising research.
Copyright © 2011. Published by Elsevier Ltd.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21824805     DOI: 10.1016/j.mib.2011.07.009

Source DB:  PubMed          Journal:  Curr Opin Microbiol        ISSN: 1369-5274            Impact factor:   7.934


  17 in total

Review 1.  Lipids at the interface of virus-host interactions.

Authors:  Vineela Chukkapalli; Nicholas S Heaton; Glenn Randall
Journal:  Curr Opin Microbiol       Date:  2012-06-09       Impact factor: 7.934

2.  Type III Interferon Restriction by Porcine Epidemic Diarrhea Virus and the Role of Viral Protein nsp1 in IRF1 Signaling.

Authors:  Qingzhan Zhang; Hanzhong Ke; Anthony Blikslager; Takashi Fujita; Dongwan Yoo
Journal:  J Virol       Date:  2018-01-30       Impact factor: 5.103

3.  Localization of Protein Kinase NDR2 to Peroxisomes and Its Role in Ciliogenesis.

Authors:  Shoko Abe; Tomoaki Nagai; Moe Masukawa; Kanji Okumoto; Yuta Homma; Yukio Fujiki; Kensaku Mizuno
Journal:  J Biol Chem       Date:  2017-01-25       Impact factor: 5.157

Review 4.  Lipid droplets and peroxisomes: key players in cellular lipid homeostasis or a matter of fat--store 'em up or burn 'em down.

Authors:  Sepp D Kohlwein; Marten Veenhuis; Ida J van der Klei
Journal:  Genetics       Date:  2013-01       Impact factor: 4.562

Review 5.  Peroxisomes and the antiviral responses of mammalian cells.

Authors:  Charlotte Odendall; Jonathan C Kagan
Journal:  Subcell Biochem       Date:  2013

Review 6.  Plant peroxisomes: biogenesis and function.

Authors:  Jianping Hu; Alison Baker; Bonnie Bartel; Nicole Linka; Robert T Mullen; Sigrun Reumann; Bethany K Zolman
Journal:  Plant Cell       Date:  2012-06-05       Impact factor: 11.277

7.  Pexophagy: the selective degradation of peroxisomes.

Authors:  Andreas Till; Ronak Lakhani; Sarah F Burnett; Suresh Subramani
Journal:  Int J Cell Biol       Date:  2012-03-27

8.  A tuberous sclerosis complex signalling node at the peroxisome regulates mTORC1 and autophagy in response to ROS.

Authors:  Jiangwei Zhang; Jinhee Kim; Angela Alexander; Shengli Cai; Durga Nand Tripathi; Ruhee Dere; Andrew R Tee; Jacqueline Tait-Mulder; Alessia Di Nardo; Juliette M Han; Erica Kwiatkowski; Elaine A Dunlop; Kayleigh M Dodd; Rebecca D Folkerth; Phyllis L Faust; Michael B Kastan; Mustafa Sahin; Cheryl Lyn Walker
Journal:  Nat Cell Biol       Date:  2013-08-18       Impact factor: 28.824

Review 9.  Peroxisome-mitochondria interplay and disease.

Authors:  Michael Schrader; Joseph Costello; Luis F Godinho; Markus Islinger
Journal:  J Inherit Metab Dis       Date:  2015-02-17       Impact factor: 4.982

10.  The intracellular bacteria Chlamydia hijack peroxisomes and utilize their enzymatic capacity to produce bacteria-specific phospholipids.

Authors:  Gaelle Boncompain; Constanze Müller; Vannary Meas-Yedid; Philippe Schmitt-Kopplin; Paul B Lazarow; Agathe Subtil
Journal:  PLoS One       Date:  2014-01-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.